Designed for Fast-Acting, Short-Duration Results
In pivotal clinical studies reported by Allergan Aesthetics, some patients experienced the onset of Boey® results as early as eight hours after treatment.
The appearance of treated glabellar lines generally returned to baseline approximately two to three weeks after administration.
This shorter treatment window could appeal to patients who:
- Are considering a neuromodulator for the first time
- Want to experience a temporary preview of wrinkle-relaxing results
- Prefer a shorter commitment before choosing a longer-lasting treatment
- Have an upcoming event and want a fast-acting option
- Are uncertain about how neuromodulator treatment will affect their appearance
Results, onset, duration and suitability may vary by patient.
Boey® May Offer a “Preview” of Neuromodulator Results
One of Boey®’s most interesting potential applications is giving patients an opportunity to experience neuromodulator treatment without committing to results that may last three to four months—or longer.
Because Boey® has demonstrated a duration of approximately two to three weeks in clinical studies, it may provide an introductory option for appropriately selected patients who want to see how they look and feel with softened frown lines.
According to research cited by Allergan Aesthetics:
- 80% of surveyed consumers were open to learning about new aesthetic treatments
- 79% wished they could temporarily preview the outcome of an aesthetic treatment
Boey® could eventually help address that interest by offering a shorter-duration introduction to neuromodulator treatment.
Boey® vs. BOTOX® Cosmetic
Include a comparison table:
| Feature | Boey® | BOTOX® Cosmetic |
| Active toxin type | Botulinum toxin serotype E | Botulinum toxin serotype A |
| Intended benefit | Temporary improvement of glabellar lines | Temporary improvement of approved facial lines |
| Reported onset | As early as eight hours in Boey® studies | Varies by patient and treatment area |
| Expected duration | Approximately two to three weeks in pivotal studies | Commonly lasts several months |
| Potential role | Short-term experience or treatment preview | Established, longer-lasting neuromodulator treatment |
| U.S. status | Not currently FDA-approved | FDA-approved for specific cosmetic indications |
Follow the table with this key clarification:
Boey® is not intended to be described as a replacement for BOTOX® Cosmetic. The treatments have meaningfully different duration profiles and may serve different patient goals. BOTOX® Cosmetic is currently the only neurotoxin identified by Allergan Aesthetics as having been clinically evaluated for use following treatment with Boey®.
Boey® Approval and Regulatory Status
United States Availability
Boey® is not currently FDA-approved or available for cosmetic treatment in the United States. Its approval in Canada and positive European regulatory opinion do not authorize its use in the U.S.
Wilmington Dermatology Center will continue monitoring official regulatory developments.
What Are the Possible Side Effects of Boey®?
According to the European Medicines Agency’s summary of its positive opinion, the most commonly reported side effects include:
- Eyelid ptosis, or temporary eyelid drooping
- Brow ptosis, or temporary lowering of the eyebrow
- Mephisto sign, or unintended elevation of the outer eyebrow
Other risks may be identified in the official prescribing information applicable to each country.
If Boey® becomes FDA-approved, treatment should only be provided by a properly qualified medical professional with experience in facial anatomy, injectable treatments and the management of potential complications.
Boey® Frequently Asked Questions
What is Boey®?
Boey® is a botulinum neurotoxin serotype E injectable developed for the temporary improvement of moderate-to-severe lines between the eyebrows.
How quickly does Boey® work?
In pivotal studies, some patients experienced an onset of effect as early as eight hours after injection.
How long do Boey® results last?
Clinical study information indicates that treated glabellar lines generally returned to baseline within approximately two to three weeks.
Is Boey® the same as BOTOX®?
No. Boey® uses botulinum toxin serotype E, while BOTOX® Cosmetic uses botulinum toxin serotype A. Boey® is designed to have a much shorter duration of effect.
Is Boey® approved in the United States?
No. Boey® is not currently FDA-approved or available for cosmetic treatment in the United States.
Can Boey® help me preview BOTOX® results?
Its short duration may eventually make Boey® an option for patients who want a temporary introduction to neuromodulator treatment. However, the two products are different, and Boey® results would not guarantee an identical response to BOTOX® Cosmetic.
Can I join a Boey® waiting list?
Patients may contact WDC to express interest in future treatment updates. Availability will depend on FDA approval and WDC’s clinical evaluation of the product.
What can I use while Boey® is unavailable?
WDC currently offers established neuromodulators such as BOTOX® Cosmetic, Dysport®, Daxxify®, Jeuveau® and Xeomin®. A consultation can help determine which option best matches your goals.